Aaron Kramer
Vorstandsvorsitzender bei Trygg Pharma AS
Profil
Aaron Kramer is currently the Chief Executive Officer at Trygg Pharma AS.
Previously, he was the President-Pharmaceutical at Aker BioMarine ASA in 2010.
He holds an MBA from Harvard University and an undergraduate degree from Tufts University.
Aktive Positionen von Aaron Kramer
| Unternehmen | Position | Beginn |
|---|---|---|
Trygg Pharma AS
 Trygg Pharma AS Pharmaceuticals: MajorHealth Technology Trygg Pharma AS develops marine based omega-3 fatty acids for pharmaceutical applications. Its products consist of AKR-963 is a soft gel capsule investigational product containing highly concentrated omega-3-acid ethyl esters; and AKR-963 is a soft gel capsule investigational product containing highly concentrated omega-3-acid ethyl esters. The company was founded in 2009 and is headquartered in Oslo, Norway. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Aaron Kramer
| Unternehmen | Position | Ende |
|---|---|---|
Aker BioMarine ASA
 Aker BioMarine ASA Agricultural Commodities/MillingProcess Industries Aker BioMarine ASA engages in the marine biotechnology industry. It develops and supplies biomarine ingredients to the animal, human nutrition, and pharmaceutical markets. Its core business is harvesting, production, sales and marketing of krill based products. The company was founded in 2006 and is headquartered in Oslo, Norway. | Finanzdirektor/CFO | 11.06.2010 |
Ausbildung von Aaron Kramer
| Tufts University | Undergraduate Degree |
| Harvard University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Aker BioMarine ASA
Aker BioMarine ASA Agricultural Commodities/MillingProcess Industries Aker BioMarine ASA engages in the marine biotechnology industry. It develops and supplies biomarine ingredients to the animal, human nutrition, and pharmaceutical markets. Its core business is harvesting, production, sales and marketing of krill based products. The company was founded in 2006 and is headquartered in Oslo, Norway. | Process Industries |
Trygg Pharma AS
Trygg Pharma AS Pharmaceuticals: MajorHealth Technology Trygg Pharma AS develops marine based omega-3 fatty acids for pharmaceutical applications. Its products consist of AKR-963 is a soft gel capsule investigational product containing highly concentrated omega-3-acid ethyl esters; and AKR-963 is a soft gel capsule investigational product containing highly concentrated omega-3-acid ethyl esters. The company was founded in 2009 and is headquartered in Oslo, Norway. | Health Technology |
